Search

everythinglearnresearchcommunity

for

Search:↓

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Hypertrichosis involves excessive hair growth and needs careful diagnosis and treatment, considering its psychological effects.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

Bimatoprost is more effective than sweet almond oil for enhancing eyebrow growth.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

White piedra, a rare fungal infection, was diagnosed in two women in a northern climate.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Electrolysis is effective for permanent hair removal, but technique is key to avoid scarring, and sometimes hormonal treatment is needed for women with hirsutism.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.